Dynavax Technologies Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Dynavax Technologies heeft een totaal eigen vermogen van $681.4M en een totale schuld van $223.6M, wat de schuld-eigenvermogensverhouding op 32.8% brengt. De totale activa en totale passiva bedragen respectievelijk $1.1B en $380.6M.
Belangrijke informatie
32.8%
Verhouding schuld/eigen vermogen
US$223.56m
Schuld
| Rente dekkingsratio | n/a |
| Contant | US$763.99m |
| Aandelen | US$681.43m |
| Totaal verplichtingen | US$380.56m |
| Totaal activa | US$1.06b |
Recente financiële gezondheidsupdates
Is Dynavax Technologies (NASDAQ:DVAX) Using Debt In A Risky Way?
Oct 12
Is Dynavax Technologies (NASDAQ:DVAX) Weighed On By Its Debt Load?
Jul 12Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Mar 06These 4 Measures Indicate That Dynavax Technologies (NASDAQ:DVAX) Is Using Debt Safely
Aug 02We Think Dynavax Technologies (NASDAQ:DVAX) Can Manage Its Debt With Ease
May 03Dynavax Technologies (NASDAQ:DVAX) Seems To Use Debt Rather Sparingly
Jan 16Recent updates
Dynavax Technologies: What The Stock Buyback Means, What It Doesn't
Nov 13Dynavax Technologies Corporation (NASDAQ:DVAX) Surges 31% Yet Its Low P/S Is No Reason For Excitement
Nov 12Is Dynavax Technologies (NASDAQ:DVAX) Using Debt In A Risky Way?
Oct 12Dynavax Technologies: Slow And Steady Wins The Race
Sep 05Dynavax Technologies: A Two Trick Pony Operating With A Single Trick
Aug 23Some May Be Optimistic About Dynavax Technologies' (NASDAQ:DVAX) Earnings
Aug 14Is Dynavax Technologies (NASDAQ:DVAX) Weighed On By Its Debt Load?
Jul 12Lacklustre Performance Is Driving Dynavax Technologies Corporation's (NASDAQ:DVAX) Low P/S
May 22Dynavax: HEPLISAV-B Growth Up, Pipeline Uncertain
May 10Dynavax: Holding Firm Despite Its Missing Cash Cow
Mar 23Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Mar 06Dynavax Technologies Corporation's (NASDAQ:DVAX) Business And Shares Still Trailing The Industry
Jan 31These 4 Measures Indicate That Dynavax Technologies (NASDAQ:DVAX) Is Using Debt Safely
Aug 02Improved Earnings Required Before Dynavax Technologies Corporation (NASDAQ:DVAX) Shares Find Their Feet
Jun 02We Think Dynavax Technologies (NASDAQ:DVAX) Can Manage Its Debt With Ease
May 03Dynavax Technologies (NASDAQ:DVAX) Seems To Use Debt Rather Sparingly
Jan 16Clover, Dynavax COVID-19 vaccine gets EU GMP certificate
Sep 20Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Sep 12The Alphavaxers: Dynavax And Novavax, 2 Quarters On
Aug 22Dynavax up 8% after raising full-year guidance for key adjuvant product, Q2 beats
Aug 04Are Investors Undervaluing Dynavax Technologies Corporation (NASDAQ:DVAX) By 41%?
Jun 03Dynavax: Evolving Endemic Situation Adds To Its Risk
May 23Dynavax Technologies' (NASDAQ:DVAX) Performance Is Even Better Than Its Earnings Suggest
May 12Dynavax Technologies (NASDAQ:DVAX) Could Easily Take On More Debt
May 10Dynavax Technologies: Full Speed Ahead
Mar 01Here's Why Dynavax Technologies (NASDAQ:DVAX) Can Manage Its Debt Responsibly
Jan 28Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $926.2M ) DVAX } overtreffen de korte termijn passiva ( $70.0M ).
Langlopende schulden: De kortetermijnactiva DVAX ( $926.2M ) overtreffen de langetermijnschulden ( $310.5M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: DVAX heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van DVAX is de afgelopen 5 jaar gedaald van 453.6% naar 32.8%.
Schuldendekking: De schuld van DVAX wordt niet goed gedekt door de operationele kasstroom ( 12.2% ).
Rentedekking: Er zijn onvoldoende gegevens om te bepalen of de rentebetalingen van DVAX op haar schulden goed worden gedekt door EBIT.